NICOLÁS
MENDOZA LADRÓN DE GUEVARA
CATEDRÁTICO DE UNIVERSIDAD
Esther de
Viuda García
Publicaciones en las que colabora con Esther de Viuda García (16)
2024
-
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis
Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242
2023
-
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Population-based survey on menopausal symptoms and treatment use
Climacteric, Vol. 26, Núm. 1, pp. 47-54
2022
2021
-
Eligibility criteria for menopausal hormone therapy (MHT): A consortium of scientific societies for the use of MHT in women with medical conditions. Research protocol
Maturitas, Vol. 148, pp. 14-17
-
Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement
Maturitas, Vol. 144, pp. 4-10
2020
-
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia
Maturitas, Vol. 137, pp. 57-62
-
Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”
Maturitas
-
The thromboembolic risk in covid-19 women under hormonal treatment group
Maturitas
2018
-
21 preguntas y respuestas y 7 recomendaciones sobre anticoncepción y acné
Sociedad Española de Contracepción
-
Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study
European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 228, pp. 221-224
2017
-
Sexual health in Spanish postmenopausal women presenting at outpatient clinics
Climacteric, Vol. 20, Núm. 2, pp. 164-170
2013
-
Position of the spanish menopause society regarding the management of perimenopause
Maturitas, Vol. 74, Núm. 3, pp. 283-290
2012
-
Continuation rate of combined hormonal contraception: A prospective multicenter study
Journal of Women's Health, Vol. 21, Núm. 5, pp. 490-495
2008
-
Self-described impact of noncompliance among users of a combined hormonal contraceptive method
Contraception, Vol. 77, Núm. 4, pp. 276-282
2007
-
Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study
Contraception, Vol. 76, Núm. 2, pp. 77-83